JP Morgan Chase’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.25B | Sell |
27,784,471
-23,189,070
| -45% | -$1.87B | 0.12% | 159 |
|
|
2026
Q1 | $4.37B | Sell |
50,973,541
-2,643,153
| -5% | -$253M | 0.28% | 76 |
|
|
2025
Q4 | $5.15B | Buy |
53,616,694
+1,420,930
| +3% | +$138M | 0.32% | 60 |
|
|
2025
Q3 | $4.97B | Buy |
52,195,764
+17,132,581
| +49% | +$1.57B | 0.3% | 66 |
|
|
2025
Q2 | $3.06B | Sell |
35,063,183
-2,563,642
| -7% | -$217M | 0.2% | 107 |
|
|
2025
Q1 | $3.38B | Buy |
37,626,825
+3,201,226
| +9% | +$286M | 0.25% | 92 |
|
|
2024
Q4 | $2.75B | Buy |
34,425,599
+3,685,673
| +12% | +$319M | 0.2% | 106 |
|
|
2024
Q3 | $2.77B | Buy |
30,739,926
+2,174,873
| +8% | +$183M | 0.21% | 105 |
|
|
2024
Q2 | $2.25B | Sell |
28,565,053
-3,061,843
| -10% | -$251M | 0.18% | 117 |
|
|
2024
Q1 | $2.76B | Buy |
31,626,896
+6,241,759
| +25% | +$533M | 0.23% | 92 |
|
|
2023
Q4 | $2.09B | Buy |
25,385,137
+5,522,685
| +28% | +$421M | 0.2% | 111 |
|
|
2023
Q3 | $1.56B | Buy |
19,862,452
+213,271
| +1% | +$17.9M | 0.17% | 127 |
|
|
2023
Q2 | $1.73B | Sell |
19,649,181
-700,802
| -3% | -$60.3M | 0.19% | 118 |
|
|
2023
Q1 | $1.64B | Buy |
20,349,983
+327,737
| +2% | +$26.7M | 0.2% | 120 |
|
|
2022
Q4 | $1.56B | Sell |
20,022,246
-1,109,473
| -5% | -$89.9M | 0.21% | 116 |
|
|
2022
Q3 | $1.71B | Buy |
21,131,719
+3,708,132
| +21% | +$333M | 0.25% | 99 |
|
|
2022
Q2 | $1.56B | Sell |
17,423,587
-1,437,047
| -8% | -$146M | 0.22% | 107 |
|
|
2022
Q1 | $2.09B | Sell |
18,860,634
-433,883
| -2% | -$45.8M | 0.25% | 91 |
|
|
2021
Q4 | $2B | Sell |
19,294,517
-4,600,966
| -19% | -$533M | 0.23% | 92 |
|
|
2021
Q3 | $3B | Sell |
23,895,483
-2,043,960
| -8% | -$265M | 0.37% | 54 |
|
|
2021
Q2 | $3.22B | Buy |
25,939,443
+3,325,977
| +15% | +$418M | 0.38% | 49 |
|
|
2021
Q1 | $2.67B | Buy |
22,613,466
+1,899,168
| +9% | +$223M | 0.36% | 60 |
|
|
2020
Q4 | $2.43B | Buy |
20,714,298
+2,863,075
| +16% | +$315M | 0.36% | 57 |
|
|
2020
Q3 | $1.83B | Buy |
17,851,223
+865,762
| +5% | +$86.9M | 0.31% | 65 |
|
|
2020
Q2 | $1.56B | Buy |
16,985,461
+3,035,766
| +22% | +$291M | 0.3% | 70 |
|
|
2020
Q1 | $1.26B | Buy |
13,949,695
+438,408
| +3% | +$46.6M | 0.3% | 76 |
|
|
2019
Q4 | $1.53B | Buy |
13,511,287
+2,542,843
| +23% | +$279M | 0.29% | 74 |
|
|
2019
Q3 | $1.19B | Buy |
10,968,444
+492,666
| +5% | +$51.4M | 0.24% | 90 |
|
|
2019
Q2 | $1.02B | Sell |
10,475,778
-6,384,569
| -38% | -$583M | 0.2% | 107 |
|
|
2019
Q1 | $1.54B | Buy |
16,860,347
+289,573
| +2% | +$25.9M | 0.31% | 65 |
|
|
2018
Q4 | $1.51B | Sell |
16,570,774
-1,829,874
| -10% | -$171M | 0.35% | 60 |
|
|
2018
Q3 | $1.81B | Sell |
18,400,648
-659,878
| -3% | -$61M | 0.35% | 52 |
|
|
2018
Q2 | $1.63B | Buy |
19,060,526
+5,845,769
| +44% | +$488M | 0.34% | 57 |
|
|
2018
Q1 | $1.06B | Buy |
13,214,757
+9,684,170
| +274% | +$799M | 0.23% | 92 |
|
|
2017
Q4 | $285M | Buy |
3,530,587
+2,249,838
| +176% | +$180M | 0.06% | 326 |
|
|
2017
Q3 | $99.5M | Buy |
1,280,749
+133,849
| +12% | +$11.1M | 0.02% | 633 |
|
|
2017
Q2 | $102M | Sell |
1,146,900
-1,174,594
| -51% | -$99M | 0.02% | 613 |
|
|
2017
Q1 | $187M | Buy |
2,321,494
+15,805
| +0.7% | +$1.23M | 0.04% | 424 |
|
|
2016
Q4 | $164M | Sell |
2,305,689
-939,600
| -29% | -$73.8M | 0.04% | 438 |
|
|
2016
Q3 | $280M | Buy |
3,245,289
+190,675
| +6% | +$16.6M | 0.07% | 293 |
|
|
2016
Q2 | $265M | Buy |
3,054,614
+819,585
| +37% | +$66.3M | 0.07% | 306 |
|
|
2016
Q1 | $168M | Sell |
2,235,029
-1,489,684
| -40% | -$112M | 0.04% | 415 |
|
|
2015
Q4 | $287M | Buy |
3,724,713
+1,199,089
| +47% | +$90.3M | 0.07% | 294 |
|
|
2015
Q3 | $169M | Sell |
2,525,624
-1,145,718
| -31% | -$84.4M | 0.05% | 399 |
|
|
2015
Q2 | $272M | Sell |
3,671,342
-1,114,743
| -23% | -$85.2M | 0.06% | 328 |
|
|
2015
Q1 | $373M | Buy |
4,786,085
+869,900
| +22% | +$65.9M | 0.09% | 264 |
|
|
2014
Q4 | $283M | Sell |
3,916,185
-198,244
| -5% | -$13.8M | 0.06% | 340 |
|
|
2014
Q3 | $255M | Buy |
4,114,429
+519,570
| +14% | +$33M | 0.06% | 352 |
|
|
2014
Q2 | $229M | Sell |
3,594,859
-814,211
| -18% | -$49.5M | 0.06% | 359 |
|
|
2014
Q1 | $271M | Buy |
4,409,070
+555,742
| +14% | +$32.4M | 0.07% | 288 |
|
|
2013
Q4 | $221M | Sell |
3,853,328
-390,089
| -9% | -$22.1M | 0.06% | 329 |
|
|
2013
Q3 | $226M | Sell |
4,243,417
-109,932
| -3% | -$5.92M | 0.07% | 303 |
|
|
2013
Q2 | $224M | Buy |
+4,353,349
| New | +$215M | 0.07% | 293 |
|
Other funds holding MDT
JP Morgan Chase's MDT Position: Q2 2026 in Review
JP Morgan Chase reduced its Medtronic (MDT) stake by 45% in Q2 2026, selling an estimated $1.87B and leaving 27,784,471 shares worth $2.25B. The position accounts for 0.12% of the portfolio, ranked #159.
JP Morgan Chase first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.15B in Q4 2025. 2,044 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- JP Morgan Chase held 27,784,471 shares of Medtronic worth $2.25B as of Q2 2026.
- JP Morgan Chase sold 23,189,070 Medtronic shares in Q2 2026, an estimated $1.87B.
- Medtronic made up 0.12% of JP Morgan Chase's portfolio in Q2 2026, its #159 holding.
- JP Morgan Chase first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Medtronic position peaked at $5.15B in Q4 2025.
- 2,044 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.